![]() |
Volumn 269, Issue 2, 2001, Pages 230-236
|
The A3 adenosine receptor as a new target for cancer therapy and chemoprotection
a,b
|
Author keywords
A3 adenosine receptor; Bone marrow; G CSF; Melanoma; Neutrophils; Synthetic A3 agonists
|
Indexed keywords
2 CHLORO N6 (3 IODOBENZYL)ADENOSINE 5' N METHYLURONAMIDE;
6 ETHYL 4 PROPYL 2 PHENYL 3 PYRIDINECARBOXYLIC ACID 5 THIOCARBOXYLIC ACID 5 ETHYL 3 PROPYL ESTER;
ADENOSINE A3 RECEPTOR;
ADENOSINE A3 RECEPTOR AGONIST;
ADENOSINE A3 RECEPTOR ANTAGONIST;
ADENOSINE RECEPTOR BLOCKING AGENT;
ADENOSINE RECEPTOR STIMULATING AGENT;
CYCLOPHOSPHAMIDE;
GRANULOCYTE COLONY STIMULATING FACTOR;
UNCLASSIFIED DRUG;
ANIMAL CELL;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
BONE MARROW;
BONE MARROW TOXICITY;
CANCER INHIBITION;
CANCER THERAPY;
CELL CYCLE;
CELL PROLIFERATION;
CONTROLLED STUDY;
DRUG EFFECT;
DRUG EFFICACY;
DRUG MECHANISM;
DRUG RECEPTOR BINDING;
LEUKOCYTE COUNT;
LUNG METASTASIS;
MELANOMA;
MOUSE;
NEUTROPHIL;
NONHUMAN;
PRIORITY JOURNAL;
|
EID: 0035478429
PISSN: 00144827
EISSN: None
Source Type: Journal
DOI: 10.1006/excr.2001.5327 Document Type: Article |
Times cited : (114)
|
References (30)
|